Harrow, Inc. 8.625% Senior Notes due 2026 (HROWL)
Harrow, Inc. 8.625% Senior Notes due 2026 (HROWL) are unsecured debt securities issued by Harrow, Inc. The notes carry a fixed interest rate of 8.625% and are scheduled to mature in 2026. They represent a means for the company to raise capital, offering investors potentially higher yields in exchange for assuming credit risk associated with the company's financial health.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| July 31, 2025 | $0.54 | 2025-07-15 | 2025-07-15 |
| April 30, 2025 | $0.54 | 2025-04-15 | 2025-04-15 |
| January 31, 2025 | $0.54 | 2025-01-15 | 2025-01-15 |
| October 31, 2024 | $0.54 | 2024-10-15 | 2024-10-15 |
| July 31, 2024 | $0.54 | 2024-07-15 | 2024-07-15 |
Dividends Summary
- Harrow, Inc. 8.625% Senior Notes due 2026 has issued 16 dividend payments over the past 4 years
- The most recent dividend was paid 85 days ago, on July 31, 2025
- The highest dividend payed out to investors during this period was $0.54 per share
- The average dividend paid during this period was $0.54 per share.
Company News
Harrow Inc. announced the acquisition of Melt Pharmaceuticals, a clinical-stage company developing a non-opioid sedation tablet (MELT-300) for medical procedures. The company plans to submit a New Drug Application to the FDA in 2027, targeting a U.S. launch in 2028.
Harrow plans to acquire Melt Pharmaceuticals for its MELT-300 sedation therapy, a non-opioid sublingual medication designed to provide rapid sedation for medical procedures. The acquisition aims to expand Harrow's procedural sedation market presence and offer an alternative to traditional IV sedation.
Dividends can fund a wonderful retirement. Today, we look at 2 amazing benefits that only dividends can provide.